Global pharma giant AstraZeneca strikes $6.9 billion deal to expand cancer portfolio

AstraZeneca plans to raise up to $3.5 billion through a share placing to fund the transaction as well as pay down debt. Analysts generally see the deal as a logical strategic move but note the equity raise may disappoint some investors.

from World News & Analysis https://ift.tt/2uHZrkp